1. Home
  2. COLM vs DYN Comparison

COLM vs DYN Comparison

Compare COLM & DYN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Columbia Sportswear Company

COLM

Columbia Sportswear Company

HOLD

Current Price

$63.77

Market Cap

3.0B

ML Signal

HOLD

DYN

Dyne Therapeutics Inc.

HOLD

Current Price

$17.81

Market Cap

3.1B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
COLM
DYN
Founded
1938
1984
Country
United States
United States
Employees
N/A
N/A
Industry
Apparel
Medicinal Chemicals and Botanical Products
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
3.0B
3.1B
IPO Year
1997
2020

Fundamental Metrics

Financial Performance
Metric
COLM
DYN
Price
$63.77
$17.81
Analyst Decision
Buy
Strong Buy
Analyst Count
7
14
Target Price
$62.50
$37.00
AVG Volume (30 Days)
550.9K
1.3M
Earning Date
04-30-2026
05-04-2026
Dividend Yield
2.00%
N/A
EPS Growth
N/A
N/A
EPS
0.65
N/A
Revenue
$3,042,478,000.00
N/A
Revenue This Year
$3.73
N/A
Revenue Next Year
$3.29
N/A
P/E Ratio
$94.25
N/A
Revenue Growth
N/A
N/A
52 Week Low
$47.48
$8.25
52 Week High
$67.91
$25.00

Technical Indicators

Market Signals
Indicator
COLM
DYN
Relative Strength Index (RSI) 62.45 49.12
Support Level $53.13 $16.57
Resistance Level $64.87 $19.52
Average True Range (ATR) 2.16 0.98
MACD 0.13 -0.05
Stochastic Oscillator 89.85 59.29

Price Performance

Historical Comparison
COLM
DYN

About COLM Columbia Sportswear Company

Columbia Sportswear Co makes outdoor and active-lifestyle apparel, footwear, equipment, and accessories that it sells under four primary brands: Columbia, Sorel, Mountain Hardwear, and prAna. The majority of sales are in the United States, but the company also has remarkable sales in its three other geographic segments: Latin American and Asia-Pacific; Europe, Middle East, and Africa; and Canada. The majority of sales are through wholesale channels, including sporting goods and department stores, but the company also operates its own branded stores in each of its geographic segments. It sources products from around the world and uses contract manufacturers outside the United States, predominantly in Asia to manufacture its various products.

About DYN Dyne Therapeutics Inc.

Dyne Therapeutics Inc is a clinical-stage neuromuscular disease company focused on discovering and advancing life-transforming therapeutics for people living with genetically driven neuromuscular diseases. Its FORCE platform develops targeted therapeutics that are designed to overcome limitations in delivery to muscle tissue and the central nervous system, or CNS. Its FORCE platform therapeutics consist of a payload that is rationally designed to target the genetic basis of the disease being treated, a linker, and an antigen-binding fragment that attaches to the payload using the linker. Its Pipeline includes DYNE-101, DYNE-251, DYNE-302, and DYNE-401.

Share on Social Networks: